Description

In this episode of the Oncology Brothers podcast, we welcomed Dr. Jonathan Friedberg, a leading lymphoma expert, to discuss modern treatment approaches for follicular lymphoma and mantle cell lymphoma.

Join us as we explored:

• The diagnostic workup for follicular lymphoma, including the role of bone marrow biopsy and staging imaging
• Treatment strategies for early-stage and symptomatic follicular lymphoma, including rituximab, obinutuzumab, and chemotherapy-based approaches
• The evolving role of maintenance therapy and what recent studies have shown about progression-free and overall survival
• New treatment options in relapsed/refractory follicular lymphoma, including tafasitamab and epcoritamab
• The importance of TP53 testing in mantle cell lymphoma and the evolving role of BTK inhibitors in frontline treatment
• The role of CAR T-cell therapy and bispecific antibodies in the evolving lymphoma treatment landscape

This discussion provided practical insights into current treatment algorithms and emerging strategies for patients with follicular lymphoma and mantle cell lymphoma.

Whether you're a hematologist, oncologist, advanced practice provider, nurse, pharmacist, trainee, or healthcare professional interested in lymphoma care, this episode offers an expert perspective on the rapidly evolving treatment landscape.

If you found this discussion valuable, please like the video, subscribe to the Oncology Brothers, and share your thoughts in the comments.

Listen us on:
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o 

Follow us on social media:

• ⁠X/Twitter: https://x.com/oncbrothers 
• ⁠Instagram: https://www.instagram.com/oncbrothers 
• Website: https://oncbrothers.com/ 

Subscribe for more expert discussions on hematology, oncology, lymphoma, immunotherapy, cellular therapy, targeted therapy, and advances in cancer care.

#FollicularLymphoma #MantleCellLymphoma #Lymphoma #Hematology #OncologyBrothers